We now have permission to provide this video produced by Eric Minikel and Sonia Vallabh about Antisense Oligonucleotide (ASO) Strategy to reduce PrP that was originally shown at our 2018 Annual National CJD Conference in Melbourne, Australia.
We now have permission to provide this video produced by Eric Minikel and Sonia Vallabh about Antisense Oligonucleotide (ASO) Strategy to reduce PrP that was originally shown at our 2018 Annual National CJD Conference in Melbourne, Australia.
7 days ago
2026 Transurban Bridge to Brisbane | CJD Support Group Network
click.grassrootz.com
Get ready to RUN FOR FUN when Queensland’s biggest, brightest, and best-loved fun run returns for it’s 30th Birthday in 2026! The Transurban Bridge to Brisbane will welcome an estimated 40,000 peo...3 weeks ago
ION717 trial re-opens with 3rd dosing regimen
www.cureffi.org
Ionis Pharmaceuticals is adding a third dosing regimen to PrProfile, its Phase 1/2a trial in symptomatic prion disease.4 weeks ago
Clinical Trial Update for Prion Diseases, December 2024 – CJD Support Group Network Australia
www.cjdsupport.org.au
December 2024 December 30th, 2024 – Enrolment is now complete for the Ionis Phase 1/2a clinical trial of ION717 called PrProfile for symptomatic prion disease patients. Updates will be provided as t...4 weeks ago
1 month ago
Remembering Dr. Bryon Caughey, scientist who always put people first - Bitterroot Star
bitterrootstar.com
by Michael Howell Dr. Byron Winslow Caughey passed away at his home on February 15 at the age of 68. He was a devoted husband and father, a real family [...]© 2026 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy